Jackie Garlich, OD, FAAO
Link has been copied to your clipboard.
Subscribe to 20/20 Glance for a weekly optometry headline summary in your inbox or view the archives.
Dexycu received FDA approval last week. It’s a sustained-release one-time injection of dexamethasone in the anterior chamber after cataract surgery. This gives an alternative to topical steroid drops following cataract surgery. (via)
Subscribe to 20/20 Glance for a weekly optometry headline summary in your inbox.
Most Popular on Modern Optometry
The Four Stages of Diabetic Retinopathy
Cecelia Koetting, OD, FAAO
When to Refer to a Neuro-Optometrist
Tanya Polec, OD, FCOVD
10 Podcasts You Should Be Listening to
Joshua Davidson, OD, FSLS
The Future of Optometry in America
Richard C. Edlow, OD